Despite the opposite role of NOX1 and NOX4 in HCC (the first one promoting and the second one suppressing tumor progression), the fact that most of the liver tumor cells express low levels of NOX4 [115] facilitates the use of general NOX inhibitors as promising tools in the treatment of liver cancer. This evidence concerns the gene NOX4 and liver cancer.